Evidence map›Paper›PMID 27550454›Full record

ArticleCancer research2016

INT6/EIF3E Controls the RNF8-Dependent Ubiquitylation Pathway and Facilitates DNA Double-Strand Break Repair in Human Cells.

Christelle Morris, Nozomi Tomimatsu, Sandeep Burma, Pierre Jalinot

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Christelle MorrisLaboratory of Biology and Modelling of the Cell, CNRS UMR 5239, INSERM U1210, ENS de Lyon, University of Lyon, Lyon, France.
Nozomi TomimatsuDivision of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Sandeep BurmaDivision of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Pierre JalinotLaboratory of Biology and Modelling of the Cell, CNRS UMR 5239, INSERM U1210, ENS de Lyon, University of Lyon, Lyon, France. pjalinot@ens-lyon.fr.
The University of Texas Southwestern Medical Center · USUniversité Claude Bernard Lyon 1 · FR

Funding

Molecular mechanisms of GBM radioresistance and strategies for radiosensitizationR01CA149461 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BURMA, SANDEEP · 2011 to 2015
$1.6M
Mechanisms of EXO1 regulation in response to radiation-induced DNA damageR01CA197796 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BURMA, SANDEEP · 2016 to 2020
$1.6M
Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastomaR21CA202403 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BURMA, SANDEEP · 2016 to 2017
$388k
NCI NIH HHS R01 CA149461NCI NIH HHS R01 CA197796NCI NIH HHS R21 CA202403
6 · The paper itself

Abstract

Unrepaired DNA double-strand breaks (DSB) are the most destructive chromosomal lesions driving genomic instability, a core hallmark of cancer. Here, we identify the antioncogenic breast cancer factor INT6/EIF3E as an essential regulator of DSB repair that promotes homologous recombination (HR)-mediated repair and, to a lesser extent, nonhomologous end-joining repair. INT6 silencing impaired the accrual of the ubiquitin ligase RNF8 at DSBs and the formation of ubiquitin conjugates at DSB sites, especially Lys63-linked polyubiquitin chains, resulting in impaired recruitment of BRCA1, BRCA2, and RAD51, which are all involved in HR repair. In contrast, INT6 deficiency did not affect the accumulation of RNF168, 53BP1, or RPA at DSBs. In INT6-silenced cells, there was also an alteration in DNA damage-induced localization of MDC1, a key target for ATM phosphorylation, which is a prerequisite for RNF8 recruitment. The attenuated DNA damage localization of RNF8 resulting from INT6 depletion could be attributed to the defective retention of ATM previously reported by us. Our findings deepen insights into how INT6 protects against breast cancer by showing how it functions in DSB repair, with potential clinical implications for cancer therapy. Cancer Res; 76(20); 6054-65. ©2016 AACR.

Indexed as

DNA Breaks, Double-StrandedDNA RepairUbiquitinationAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsBRCA2 ProteinBreast NeoplasmsCell Cycle ProteinsDNA-Binding ProteinsEukaryotic Initiation Factor-3FemaleHeLa CellsHomologous RecombinationHumansNuclear ProteinsRad51 RecombinaseAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATM protein, humanBRCA2 ProteinBRCA2 protein, humanCell Cycle ProteinsDNA-Binding ProteinsEukaryotic Initiation Factor-3MDC1 protein, humanNuclear ProteinsRAD51 protein, humanRad51 RecombinaseRNF8 protein, humanTrans-ActivatorsUbiquitin-Protein Ligases

Identifiers

PMID27550454
PMCPMC5065779
OpenAlexW2518553043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.